Arina Kochetkova

Biomedical Research technician with work history at the fast-paced pharmaceutical production and research laboratory environments. Knowledgeable in quality control measures and (non) routine biomedical laboratory practices, data analysis and effective collaboration with interdisciplinary teams. As a young specialist, I am very enthusiastic to embrace new challenges and contribute to the success of the company.

Date of Birth: 31/07/2000 

Gender: Female 

Nationality: Russian 

Current visa deadline: 01/09/2025

Kelly Vellinga-Chan, Tutor and Internship supervisor (contacts available upon request): I have no doubt that she will be an excellent ambassador of the qualities and standards that the future position upholds. I therefore have no hesitation in recommending her.

• Administration of an LXR agonist promotes atherosclerotic lesion remodeling in murine inflammatory arthritis, 2023, Dragana Dragoljevic et al, Clinical & Translational Immunology, 12(4)
• Obesity-induced TET2 disfunction in DNMT3A mutated haematopoietic cells increases myelopoiesis, resulting in increased risk for cardiovascular disease development, 2023, HBO Kennisbank
• Investigating the role of AMPK-mediated TET2 in diabetes-induced myelopoiesis and the effect of Vitamin C on restoring TET2 function, 2023, HBO Kennisbank

• HAN Excellence and Holland Scholarship, 2019-2023 from HAN University of Applied Science: was awarded throughout four years of study and was based on academic success.
• The internship allowance, 2022-2023 from Baker Heart and Diabetes Institute: was equal to the PhD stipend in Australia and was offered for a whole period of the internship (one year).
• Engineering Grant, 2022-2023 from HAN University of Applied Science: was awarded twice as a scholarship for non-Erasmus internship students